ArticleBMJ paediatrics open2025
Oxygenation indices and echocardiographic markers of pulmonary hypertension and ventricular dysfunction in congenital diaphragmatic hernia.
Article in BMJ paediatrics open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Correlation of Oxygen Saturation Index with Oxygenation Index in Congenital Diaphragmatic Hernia: in A Secondary Analysis of a Randomized Clinical Trial.The Journal of pediatrics · 2026Article
- Adding Early Postnatal Parameters of Ventilation to Prognostic Models for Pulmonary Outcome in Very Preterm Infants.Pediatric pulmonology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the relationship between early oxygenation indices (oxygenation index (OI) and oxygen saturation index (OSI)) and echocardiographic markers of ventricular dysfunction and pulmonary hypertension in neonates with congenital diaphragmatic hernia (CDH).
designSingle-centre retrospective cohort study.
settingLevel III neonatal intensive care unit at King Abdulaziz Medical City, Riyadh, Saudi Arabia. PATIENTS: A total of 47 neonates with CDH admitted between 2016 and 2024 were included. Infants with major congenital heart disease or chromosomal anomalies were excluded.
main outcome measuresCorrelation of OI and OSI within the first 48 hours with echocardiographic markers of ventricular function, pulmonary hypertension and Vasoactive-Inotropic Score (VIS).
resultsAmong 47 infants, survival was 70%. Survivors had higher left ventricular ejection fraction (M-mode: 61% vs 40%, p=0.010) and more preserved speckle-tracking strain (-17% vs -11%, p=0.006). Non-survivors had elevated right ventricular systolic pressure (RVSP) (68 vs 40 mm Hg, p=0.001), greater systolic eccentricity index (1.9 vs 1.4, p=0.002) and a higher percentage of right-to-left patent ductus arteriosus (PDA) shunting (50% vs 11%, p<0.001). Higher best, mean and highest OI and OSI values were significantly correlated with impaired ventricular function, elevated RVSP and greater right-to-left PDA flow. VIS was strongly correlated with all oxygenation indices, with the strongest correlations observed for mean OSI (r=0.851, p<0.001) and mean OI (r=0.812, p<0.001). Receiver operating characteristic analysis showed that RVSP had the strongest predictive accuracy for survival (area under the curve (AUC) 0.985, sensitivity 98% and specificity 97%), followed by the percentage of right-to-left PDA shunting (AUC 0.847) and left ventricular output (AUC 0.825).
conclusionsElevated oxygenation indices within the first 48 hours are associated with biventricular dysfunction, pulmonary hypertension and higher inotropic support requirements in CDH. Integration of early oxygenation measures and echocardiographic assessment may enhance risk stratification and guide therapeutic decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.